Autoinflammatory & rare systemic diseases

Establishment of a differential diagnosis method and an online prediction platform for adult-onset Still's disease (AOSD) and sepsis based on gradient boosting decision trees algorithm

Arthritis Res TherPublished Diagnostic accuracy study

Authors' conclusion

We created a method for the identification of AOSD and sepsis based on machine learning.

Study context

Population
AOSD and sepsis patients admitted to Affiliated Hospital of Xuzhou Medical University, December 2018 to December 202142 AOSD, 50 sepsis
Comparison
Gradient boosting decision tree (GBDT) optimization model for differential diagnosis of AOSD vs sepsis
Outcome
Differential diagnosis of AOSD vs sepsis (AUC, accuracy, sensitivity, specificity)
Methodological detailsmachine learning model development, external validation, single-centre, Online platform AIADSS: http://cppdd.cn/STILL1/, Feature selection with SHAP; models built with scikit-learn in Python
  • Machine learning model development
  • External validation
  • Single-centre
  • Online platform AIADSS: http://cppdd.cn/STILL1/
  • Feature selection with SHAP; models built with scikit-learn in Python

Performance

As reported in the abstract

Discrimination of AOSD vs sepsis by GBDT model (arthralgia, ferritin × lymphocyte count, WBC count, ferritin × platelet count, α1-acid glycoprotein/creatine kinase)
Test or modelAUCACCSensSpec
Training set0.99160.94570.95560.9578
External validation0.98000.93330.80001.000

AUC

Training set0.9916
External validation0.9800

ACC

Training set0.9457
External validation0.9333

Sens

Training set0.9556
External validation0.8000

Spec

Training set0.9578
External validation1.000

Original publication

Establishment of a differential diagnosis method and an online prediction platform for AOSD and sepsis based on gradient boosting decision trees algorithm. Arthritis Res Ther. Published 16 November 2023. doi:10.1186/s13075-023-03207-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.